Jazz Pharmaceuticals (JAZZ) Debt Ratio (2010 - 2026)

Jazz Pharmaceuticals' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.45 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 3.53% year-over-year to 0.45 in Q1 2026; TTM through Mar 2026 was 0.45, a 3.53% decrease from a year earlier, with the FY2025 full-year figure at 0.55, up 7.74% from the prior year.
• Debt Ratio eased to 0.45 in Q1 2026 per JAZZ's latest filing, from 0.55 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.58 in Q2 2025 and bottomed at 0.45 in Q1 2026.
• The 5-year median for Debt Ratio is 0.51 (2022), against an average of 0.52.
• Across the five-year window, Debt Ratio surged 64.55% in 2022 and retreated 8.0% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.53 in 2022, then slipped by 5.09% to 0.5 in 2023, then increased by 1.42% to 0.51 in 2024, then climbed by 7.74% to 0.55 in 2025, then fell by 17.59% to 0.45 in 2026.
• Per Business Quant, the three latest JAZZ Debt Ratio figures stand at 0.45 (Q1 2026), 0.55 (Q4 2025), and 0.56 (Q3 2025).